Hybridization is an essential step in medium resolution DNA and RNA analysis. DiagCor’s flexible flow-through hybridization platform simplifies lab workflow and reduces overheads.
We have developed our core technology into a range of molecular and cytogenetic services. Our products and services spans prenatal diagnosis, genetic testing, parentage investigation, cancer testing and infectious disease identification.
Our research and development pipeline includes tests in other areas such as cancer biomarker identification and pharmacogenomics.